References
1.Shapiro D, Harel M, Ferrer F, McKenna PH. Focusing on organ preservation and function: paradigm shifts in the treatment of pediatric genitourinary rhabdomyosarcoma. Int Urol Nephrol 2016; 48: 1009-1113.
2.Soler R, Jr Macedo A, Bruschini H, Puty F, Caran E, Petrilli A, Garrone G, Srougi M, Ortiz V. Does the less aggressive multimodal approach of treating bladder-prostate rhabdomyosarcoma preserve bladder function? J Urol 2005; 174: 2343-6.
3.Yeung CK, Ward HC, Ransley PG, Duffy PG, Pritchard J. Bladder and kidney function after cure of pelvic rhabdomyosarcoma in childhood. Br J Cancer 1994; 70: 1000–1003.
4. Raney B, Heyn R, Hays DM, Tefft M, Newton WA, Wharam M, Vassilopoulou-Sellin R, Maurer HM. Sequelae of treatment in 109 patients followed for 5 to 15 years after diagnosis  of sarcoma of the bladder and prostate. A report from the Intergroup Rhabdomyosarcoma Study Committee. Cancer 1993, 71: 2387–2394.
5. Hays DM, Raney RB, Wharam MD, Wiener E, Lobe TE, Andrassy RJ, Lawrence W, Johnston J, Webber B, Maurer HM. Children with vesical rhabdomyosarcoma (RMS) treated by partial cystectomy with neoadjuvant or adjuvant chemotherapy, with or without radiotherapy. A report from the Intergroup Rhabdomyosarcoma Study (IRS) Committee. J Pediatr Hematol Oncol 1995; 17: 46–52.
6. Martelli H, Haie-Meder C, Branchereau S, Franchi-Abella S, Ghigna M, Dumas I, Bouvet N, Oberlin O. Conservative surgery plus brachytherapy treatment for boys with prostate and/or bladder neck rhabdomyosarcoma: a single team experience. J Pediat Surg 2009; 44:190–196.
7. Chargari C, Haie-Meder C, Guérin F, Minard-Colin V, lambert G, Mazeron R, Escande A, Marsolat F, Dumas I, Deutsch E, Valteau-Couanet D, Audry G, Oberlin O, Martelli H. Brachytherapy Combined With Surgery for Conservative Treatment of Children With Bladder Neck and/or Prostate Rhabdomyosarcoma. Int J Radiat Onc Biol Phys 2017; 98: 352–359.
8. Fuchs J, Paulsen F, Bleif M, Lamprecht U, Weidner N, Zips D, Neunhoeffer F, Seitz G. Conservative surgery with combined high dose rate brachytherapy for patients suffering from genitourinary and perianal rhabdomyosarcoma. Radiother Oncol 2016; 212: 262-7.
9. Nag S, Tippin D, Ruymann F. Long-term morbidity in children treated with fractionated high-dose-rate brachytherapy for soft tissue sarcomas. J Pediatr Hematol Oncol 2003; 25: 448-452.
10. Viani G, Novaes P, Jacinto A, Antonelli CB, Pellizon AC, Saito EY, Salvajoli J. High-dose brachyterapy for soft tissue sarcoma in children: a single institution experience. Radiat Oncol 2008, 3:9.
11. Chargari C, Martelli H, Guerin F, Bacorro W, Lambert G, Escande A, Minar-Colin V, Dumas I, Deutsch E, Haie-Meder C. Pulsed-dose rate brachytherapy for pediatric bladder prostate rhabdomyosarcoma: compliance and early clinical results. Radiother Oncol 2017; 124:285-90.
12. Ep SSG RMS 2005 - a Protocol for non metastatic rhabdomyosarcoma, https://www.skion.nl/workspace/uploads/Protocol-EpSSG-RMS-2005-1-3-May-2012_1.pdf.
13. Hoskin PJ, Colombo A, Henry A, Niehoff P, Hellebust TP, Siebert F, Kovacs G. GEC/ESTRO recommendations on high dose rate afterloading brachytherapy for localised prostate cancer: An update. Radiother Oncol 2013; 107:325–32.
14. Pötter R, Tanderup K, Kirisits C, et al. The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies. Clin Transl Radiat Oncol 2018; 9:48–60.
15. Leeuwen CM, Oei AL, Crezee J,Bel A, Franken NAP, Stalpers LJA, Kok HP. The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies. Radiat Oncol 2018;13:96.
16. Rivard MJ, Coursey BM, DeWerd LA, et al. Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations. Med Phys 2004;31:633–74.
17. Hjälmås K. Urodynamics in normal infants and children. Scand J Urol Nephrol 1988; S114: 20–7.
18. Holmdahl G, Hanson E, Hansom M, Hellström AL, Hjälmås K, Sillén U. Four-hour voiding observation in healthy infants. J Urol 1996;156:1809–12.
19. Rodeberg DA, Anderson JR, Arndt CA, Ferrer FA, et al. Comparison of outcomes based on treatment algorithms for rhabdomyosarcoma of the  bladder/prostate: combined results from the Children’s Oncology Group, German Cooperative Soft Tissue Sarcoma Study, Italian Cooperative Group, and International Society of Pediatric Oncology Malignant Mesenchymal Tumours Committee, Int J Cancer 2011; 128:1232–1239.
20. Schimdt A, Warmann S, Eckert F, Ellerkamp V, Schaefer J, Blumenstock G, Paulsen F, Fuchs J. The Role of Reconstructive surgery and brachytherapy in pediatric Bladder/prostate rhabdomyosarcoma, J Urol 2020; 204: 826-834.